Overview

3DIcon Corporation (OTCBB: TDCP)

3DIcon Corporation is a developer of groundbreaking 3D projection and display technologies that are being designed to produce full color, 360° volumetric images. 3DIcon's mission is to create true-to-life 3D images that occupy 3D space and appear solid as viewed from any angle with the naked eye. The Company is targeting a myriad of applications for its developing technologies. These commercial applications, which are projected to approach a market size of well over $1 billion by 2011, include scanning for medical and homeland security needs; geo-spatial imaging for oil & gas exploration and air traffic control; entertainment; advertising; and gaming. The Company has recently launched its first product, Pixel Precision®, a software system that serves the R&D market for Texas Instruments' DLP® technology. 

Quick Links

Share Statistics


Shareholder Letter
from Sid Aroesty


Outstanding: 1,189,361,632
Float: 129,306,160
Shareholder Contact: info@3dicon.net  

Important Company Highlights

  • Intellectual Property Portfolio: 3DIcon own the exclusive worldwide rights to a portfolio of technologies developed by OU, under the auspices of its SRA.
  • Research at the University of Oklahoma: 3DIcon’s technologies are being developed by leading researchers and scientists in multiple disciplines on two University of Oklahoma campuses.
  • $1 billion Market by 2011: The market for 3D display technologies is expected to reach over $1 billion by 2011.
  • CSpace®: Achieved one-color projection into projection medium embedded with light sensitive nano-materials.
  • Pixel Precision®: Launched distribution and sales of software product that targets the R&D market for Texas Instruments’ DLP® technology.

Recent News

Company Information

3DIcon Corporation
6804 South Canton Avenue
Suite 150
Tulsa, OK 74136

CEO: Sid Aroesty
Employees/Consultants: 4

Issue Type: Common Stock
Sector: Technology
Industry: Telecommunications

Management Team

Sid Aroesty
Chief Executive Officer

Dr. Hakki Refai
Chief Technology Officer

Dr. Brian Hoover
Vice President, Technology Development

Dr. James Sluss
Principal Investigator

Judith F. Keating
Corporate Secretary

Chris Dunstan
Interim Chief Financial Officer

Technology Advisory Board

Vivek Bhaman
Chairman of Technical Advisory Board

Dr. Thomas W. Allen
Director of Medical and Educational Applications and Director of Corporate Wellness

Investor Relations

Tel: (918) 494-0509